Salmond, R.J., Mirchandani, A.S., Besnard, A.-G., Bain, C.C., Thomson, N.C. and Liew, F.Y. (2012) IL-33 induces innate lymphoid cell–mediated airway inflammation by activating mammalian target of rapamycin. Journal of Allergy and Clinical Immunology, 130(5), pp. 1159-1166. (doi: 10.1016/j.jaci.2012.05.018)

Komai-Koma, M. et al. (2012) Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy, 67(9), pp. 1118-1126. (doi: 10.1111/j.1398-9995.2012.02859.x) (PMID:22702477) (PMCID:PMC3660789)

Liew, F.Y. (2012) IL-33: a Janus cytokine. Annals of the Rheumatic Diseases, 71(Sup. 2), i101-i104. (doi: 10.1136/annrheumdis-2011-200589)

Turnquist, H. R. et al. (2011) IL-33 expands suppressive CD11b+ Gr-1int and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. Journal of Immunology, 187(9), pp. 4598-4610. (doi: 10.4049/jimmunol.1100519)

Hueber, A. J., Alves-Filho, J. C., Asquith, D. L., Michels, C., Millar, N. L. , Reilly, J. H., Graham, G. J. , Liew, F. Y., Miller, A. M. and McInnes, I. B. (2011) IL-33 induces skin inflammation with mast cell and neutrophil activation. European Journal of Immunology, 41(8), pp. 2229-2237. (doi: 10.1002/eji.201041360) (PMID:21674479)

Miller, A. M. and Liew, F. Y. (2011) The IL-33/ST2 pathway — A new therapeutic target in cardiovascular disease. Pharmacology and Therapeutics, 131(2), pp. 179-186. (doi: 10.1016/j.pharmthera.2011.02.005)

Kurowska-Stolarska, M. et al. (2011) MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proceedings of the National Academy of Sciences of the United States of America, 108(27), pp. 11193-11198. (doi: 10.1073/pnas.1019536108) (PMID:21690378)

Zaiss, M. M. et al. (2011) IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-α–mediated bone loss. Journal of Immunology, 186(11), pp. 6097-6105. (doi: 10.4049/jimmunol.1003487) (PMID:21515798)

Niedbala, W., Alves-Filho, J. C., Fukada, S. Y., Vieira, S. M., Mitani, A., Sonego, F., Mirchandani, A., Nascimento, D. C., Cunha, F. Q. and Liew, F. Y. (2011) Regulation of type 17 helper T-cell function by nitric oxide during inflammation. Proceedings of the National Academy of Sciences of the United States of America, 108(22), pp. 9220-9225. (doi: 10.1073/pnas.1100667108)

Culshaw, S. , McInnes, I. B. and Liew, F. Y. (2011) What can the periodontal community learn from the pathophysiology of rheumatoid arthritis? Journal of Clinical Periodontology, 38(S11), pp. 106-113. (doi: 10.1111/j.1600-051X.2010.01669.x) (PMID:21323707)

Kinane, D. F. et al. (2011) Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions - consensus of the Seventh European Workshop on Periodontology. Journal of Clinical Periodontology, 38(S11), pp. 44-48. (doi: 10.1111/j.1600-051X.2010.01682.x)

Komai-Koma, M., Gilchrist, D. S., McKenzie, A. N. J., Goodyear, C. S. , Xu, D. and Liew, F. Y. (2011) IL-33 activates B1 cells and exacerbates contact sensitivity. Journal of Immunology, 186(4), pp. 2584-2591. (doi: 10.4049/jimmunol.1002103)

Stolarski, B., Kurowska-Stolarska, M. , Kewin, P., Xu, D. and Liew, F. Y. (2010) IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation. Journal of Immunology, 185(6), pp. 3472-3480. (doi: 10.4049/jimmunol.1000730)

Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M. , McKenzie, A. N., Xu, D., Sattar, N. , McInnes, I. B. and Liew, F. Y. (2010) Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circulation Research, 107(5), pp. 650-658. (doi: 10.1161/CIRCRESAHA.110.218867) (PMID:20634488) (PMCID:PMC4254700)

Verri, W. A. et al. (2010) IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Annals of the Rheumatic Diseases, 69(9), pp. 1697-1703. (doi: 10.1136/ard.2009.122655) (PMID:20472598)

McLaren, J. E., Michael, D. R., Salter, R. C., Ashlin, T. G., Calder, C. J., Miller, A. M., Liew, F. Y. and Ramji, D. P. (2010) IL-33 Reduces Macrophage Foam Cell Formation. Journal of Immunology, 185(2), pp. 1222-1229. (doi: 10.4049/jimmunol.1000520)

Xu, D. et al. (2010) IL-33 exacerbates autoantibody-induced arthritis. Journal of Immunology, 184(5), pp. 2620-2626. (doi: 10.4049/jimmunol.0902685) (PMID:20139274)

Liew, F. Y., Pitman, N. I. and McInnes, I. B. (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nature Reviews Immunology, 10(2), pp. 103-110. (doi: 10.1038/nri2692) (PMID:20081870)

Asquith, D. L., Miller, A. M., Hueber, A. J., Liew, F. Y., Sattar, N. and McInnes, I. B. (2010) Apolipoprotein E-deficient mice are resistant to the development of collagen-induced arthritis. Arthritis and Rheumatism, 62(2), pp. 472-477. (doi: 10.1002/art.27205) (PMID:20112375)

Alves Filho, J. C. et al. (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nature Medicine, 16(6), pp. 708-712. (doi: 10.1038/nm.2156)

Murphy, G.E.J., Xu, D., Liew, F.Y. and McInnes, I.B. (2010) Role of interleukin 33 in human immunopathology. Annals of the Rheumatic Diseases, 69(Suppl), pp. 43-47. (doi: 10.1136/ard.2009.120113) (PMID:19995743)

Pushparaj, P. N., Tay, H. K., H'Ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. Y. and Melendez, A. J. (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proceedings of the National Academy of Sciences of the United States of America, 106(24), pp. 9773-9778. (doi: 10.1073/pnas.0901206106)

Komai-Koma, M., Gilchrist, D. S. and Xu, D. (2009) Direct recognition of LPS by human but not murine CD8⁺ T cells via TLR4 complex. European Journal of Immunology, 39(6), pp. 1564-1572. (doi: 10.1002/eji.200838866)

McKimmie, C. S. et al. (2009) A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. Blood, 113(18), pp. 4224-4231. (doi: 10.1182/blood-2008-08-174698) (PMID:19202130)

Lemos, H. P. et al. (2009) Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNγ  production. Proceedings of the National Academy of Sciences of the United States of America, 106(14), pp. 5954-5959. (doi: 10.1073/pnas.0812782106) (PMID:19289819)

Trieu, A., Bokil, N., Dunn, J. A., Roberts, T. L., Xu, D., Liew, F. Y., Hume, D. A., Stacey, K. J. and Sweet, M. J. (2009) TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium. Immunology and Cell Biology, 87(3), pp. 218-225. (doi: 10.1038/icb.2008.95)

Jiang, H., Al Rasebi, Z., Mensah-Brown, E., Shahin, A., Xu, D., Goodyear, C. , Fukada, S., Liu, F., Liew, F. and Lukic, M. (2009) Galectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 182(2), pp. 1167-1173.

Kurowska-Stolarska, M. et al. (2008) IL-33 induces antigen-specific IL-5⁺ T cells and promotes allergic-induced airway inflammation independent of IL-4. Journal of Immunology, 181(7), pp. 4780-4790.

McKimmie, C. S. et al. (2008) Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. Journal of Immunology, 181(5), pp. 3353-3363. (doi: 10.4049/jimmunol.181.11.8170-a) (PMID:19039854)

Xu, D. et al. (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences of the United States of America, 105(31), pp. 10913-10918. (doi: 10.1073/pnas.0801898105) (PMID:18667700) (PMCID:PMC2491487)

Grespan, R., Fukada, S. Y., Lemos, H. P., Vieira, S. M., Napimoga, M. H., Teixeira, M. M., Fraser, A. R., Liew, F. Y., McInnes, I. B. and Cunha, F. Q. (2008) CXCR2‐specific chemokines mediate leukotriene B4–dependent recruitment of neutrophils to inflamed joints in mice with antigen‐induced arthritis. Arthritis and Rheumatism, 58(7), pp. 2030-2040. (doi: 10.1002/art.23597) (PMID:18576322)

Turnquist, H. R., Sumpter, T. L., Tsung, A., Zahorchak, A. F., Nakao, A., Nau, G. J., Liew, F. Y., Geller, D. A. and Thomson, A. W. (2008) IL-1β-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells. Journal of Immunology, 181(1), pp. 62-72. (doi: 10.4049/jimmunol.181.1.62)

Yang, C.-H., Tian, L., Ling, G.-S., Trendell-Smith, N. J., Ma, L., Lo, C.-K., Stott, D. I., Liew, F. Y. and Huang, F.-P. (2008) Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: Roles of IL-2 versus IL-15. European Journal of Immunology, 38(6), pp. 1664-1676. (doi: 10.1002/eji.200838190)

Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N. , Baker, A. H., McInnes, I. B. and Liew, F. Y. (2008) IL-33 reduces the development of atherosclerosis. Journal of Experimental Medicine, 205(2), pp. 339-346. (doi: 10.1084/jem.20071868) (PMID:18268038) (PMCID:PMC2271006)